In our penultimate JP Morgan 2023 interview, pharmaphorum editor-in-chief Jonah Comstock caught up with Lisa Yañez, CEO of Aerami Therapeutics, at the Fairmont Hotel.
Robin Roberts, COO and co-founder of the Novartis Biome, was on site at JP Morgan last month in San Francisco, but we weren’t able to pin him down for an interview.
Fred Turner is CEO of Curative, a company that’s just announced a head-scratching pivot: from COVID-testing company to large-group commercial health plan.
This week, pharmaphorum editor-in-chief Jonah Comstock and pharmaphorum founder Paul Tunnah headed to San Francisco for the JP Morgan conference, the annual elbow-rubbing opportunity for biotech bi
We’re preparing to start JP Morgan week with a busy day Monday, with day 1 of the Informa Biotech Showcase, including a dedicated mini-event on Cell and Gene Therapy in the morning.
Bavarian Nordic is preparing to file for regulatory approval of a vaccine against chikungunya virus after its CHIKV VLP candidate showed protective efficacy in a second ph
To improve trial recruitment, engagement, and retention, and to increase the likelihood that trials reflect what matters most to patients, regulatory authorities increasingly point to metho